Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

NCT04027361 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Amphetamine Extended Release (ER) Tablet 20 mg

Sponsor

Tris Pharma, Inc.

Collaborators

[object Object]
[object Object]